Vascular News and Research

RSS

Medtronic launches Captivia Delivery System for Valiant Thoracic Stent Graft

Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.

9 Oct 2009

Clarian Cardiovascular offers transradial cardiac catheterization

Clarian Cardiovascular has established the Midwest’s only Transradial Center of Excellence in an effort to offer patients a catheterization procedure that significantly reduces recovery time and improves patient outcomes – transradial cardiac catheterization.

9 Oct 2009

CHI announces its agenda for the 2009 California Healthcare Policy Forum

CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.

9 Oct 2009

CardioPharma to submit an NDA for CardiaPill

CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill. "The recent news from Kaiser Permanente reinforces that in this cost containment and efficacy oriented healthcare environment, CardiaPill is in the right place at the right time," stated Don Sellers, CardioPharma's Chairman and CEO.

9 Oct 2009

Beth Israel Deaconess Medical Center neurologist elected as ANA Honorary Member

Louis R. Caplan, MD, Senior Neurologist at Beth Israel Deaconess Medical Center (BIDMC) and a leader in the treatment and research of strokes, has been elected an Honorary Member of the American Neurological Association (ANA). As the organization's highest honor, Honorary Membership is reserved for select individuals who have made unique contributions to neurology and neurological science throughout their careers.

8 Oct 2009

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.

From Quest Diagnostics 8 Oct 2009

Lifeline Vascular Access receives re-accreditation from Joint Commission

Lifeline Vascular AccessSM, the nation’s leading provider of vascular access management services, announced today that it has been re-accredited by the Joint Commission - demonstrating compliance with the Joint Commission’s national standards for health care quality and safety.

8 Oct 2009

AGA Medical's patent on occlusion devices upheld

AGA Medical Holdings, Inc. today announced that a five-judge panel in the German Federal Patent Court in Munich has upheld the validity of an important AGA Medical patent. The court rejected a lawsuit brought by Occlutech GmbH that contended that AGA Medical's patent did not meet the standards of patentability under German law.

8 Oct 2009

Researchers succeed in engineering human tissue patches from stem cells

University of Washington (UW) researchers have succeeded in engineering human tissue patches free of some problems that have stymied stem-cell repair for damaged hearts.

8 Oct 2009

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards.

8 Oct 2009

Susquehanna Health acquires a Daxor blood volume analyzer

Daxor Corporation, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Susquehanna Health of Williamsport, Pennsylvania. This will provide Susquehanna Health with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume.

8 Oct 2009

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths.

8 Oct 2009

DATATRAK International to evaluate treatment of peripheral vascular disease

DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of a new client with the award of a study for evaluating the use of a thoracic stent graft in aneurysm repair.

8 Oct 2009

Arizona Heart Institute partners with Arizona Research Center for the advancement of cardiovascular therapies

Arizona Heart Institute, a world leading medical facility specializing in diagnosis, treatment and prevention of heart and vascular disease, and Arizona Research Center, a dedicated provider of clinical research studies, announce a partnership in the advancement of cardiovascular therapies.

7 Oct 2009

Uterine artery embolization proves to be better than laparoscopic occlusion of uterine arteries in treating fibroids

BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.

7 Oct 2009

Award-winning GWTG hospitals have lower mortality rates for heart attack and heart failure patients: Study

Hospitals receiving performance awards from the American Heart Association's Get With The Guidelines (GWTG) quality improvement initiative have lower mortality rates for heart attack and heart failure patients than all other hospitals, according to a new study.

7 Oct 2009

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex(®) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006.

6 Oct 2009

Researchers find increase in the number of procedures performed for dermatologic health care

Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.

6 Oct 2009

New embolization technique offers better clinical outcomes in the treatment of liver cancer

The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.

6 Oct 2009

Cardiovascular Systems to build new manufacturing facility in Texas

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed a 10-year lease agreement for a new 46,000-square-foot manufacturing facility in Pearland, Texas.

6 Oct 2009

Vascular News and Research

Medtronic launches Captivia Delivery System for Valiant Thoracic Stent Graft

Clarian Cardiovascular offers transradial cardiac catheterization

CHI announces its agenda for the 2009 California Healthcare Policy Forum

CardioPharma to submit an NDA for CardiaPill

Beth Israel Deaconess Medical Center neurologist elected as ANA Honorary Member

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

Lifeline Vascular Access receives re-accreditation from Joint Commission

AGA Medical's patent on occlusion devices upheld

Researchers succeed in engineering human tissue patches from stem cells

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

Susquehanna Health acquires a Daxor blood volume analyzer

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

DATATRAK International to evaluate treatment of peripheral vascular disease

Arizona Heart Institute partners with Arizona Research Center for the advancement of cardiovascular therapies

Uterine artery embolization proves to be better than laparoscopic occlusion of uterine arteries in treating fibroids

Award-winning GWTG hospitals have lower mortality rates for heart attack and heart failure patients: Study

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Researchers find increase in the number of procedures performed for dermatologic health care

New embolization technique offers better clinical outcomes in the treatment of liver cancer

Cardiovascular Systems to build new manufacturing facility in Texas

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News